Iovance Biotherapeutics, Inc. IOVA Change in Inventories
Change in Inventories at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Iovance Biotherapeutics, Inc.'s change in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Iovance Biotherapeutics, Inc.'s change in inventories?
- Iovance Biotherapeutics, Inc. (IOVA) reported change in inventories of $4.93M in Q1 2026.
- How has Iovance Biotherapeutics, Inc.'s change in inventories changed year-over-year?
- Iovance Biotherapeutics, Inc.'s change in inventories decreased by 64.4% year-over-year, from $13.83M to $4.93M.
- What does change in inventories mean?
- Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.